FDA NDC Directory · JSON-LD · Markdown

Diatrizoate Meglumine and Diatrizoate Sodium

NDC 31722-019 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215049
Dosage form / routeSOLUTION · ORAL RECTAL
Active ingredientsDIATRIZOATE MEGLUMINE (660 mg/mL)
DIATRIZOATE SODIUM (100 mg/mL)
Marketing started20231117
Package count2

External sources

Source: openFDA. Public-domain (CC0).